Ardsley Advisory Partners’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,224	Closed	-$217K	–	162
2020 Q3	$217K	Buy	1,224 +140	+13%	+$24.8K	0.04%	106
2020 Q2	$251K	Buy	+1,084	New	+$251K	0.05%	102